Skip to main content
SpringerLink
Log in

Komplexe endokrine Störungen

  • Chapter
Klinische Endokrinologie und Stoffwechsel

  • 217 Accesses

Zusammenfassung

Eine 23-jährige Patientin mit Typ-1-Diabetesmellitus, der seit dem dritten Lebensjahr bekannt und bisher zufrieden stellend therapiert wurde, stellte sich mit entgleister Stoffwechsellage erstmalig in der Klinik vor. Die Entgleisung wurde zunächst auf Diätfehler im Rahmen der seit kurzem bestehenden Anorexia nervosa zurückgeführt. Die Patientin konnte nach adäquater Therapie in stabilem Zustand nach Hause entlassen werden. In den folgenden Wochen kam es jedoch wiederholt zu stationären Aufnahmen wegen Elektrolyt- und Blutzuckerentgleisungen. Die Patientin klagte im Wesentlichen über Müdigkeit und Abgeschlagenheit sowie trockene Haut. Bei der klinischen Untersuchung fiel eine bräunliche Verfärbung der Handlinien auf.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Literatur zu Abschn. 9.7

  • Ahonen P., Miettinen A., Perheentupa J. (1987) Adrenal and steroidal cell antibodies in patients with auto immune polyglandular disease type land risk of adrenocortical and ovarian failure. J Clin Endocrinol Metab 64: 494–500

    Article  PubMed  CAS  Google Scholar 

  • Ahonen P., Myllarniemi S., Sipila I., et al. (1990) Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECD) in aseries of 68 patients. N Engl J Med 322: 1829–1836

    Article  PubMed  CAS  Google Scholar 

  • Badenhoop K., Walfish P.G., Rau H. et al. (1995) Susceptibility and resistance alleles of human leucocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine auto immune disease. J Clin Endocrinol Metab 80: 2112–2117

    Article  PubMed  CAS  Google Scholar 

  • Betterle C., Caretto A., DeZio A. et al. (1985) Incidence and significance of organ-specific auto immune disorders (clinical, latent or only autoantibodies) in patients with vitiligo. Dermatologica 171: 419–423

    Article  PubMed  CAS  Google Scholar 

  • Björses P., Aaltonen J., Vikman A. et al. (1996) Genetic homogeneity of autoimmune polyglandular disease type I. Am J Hum Gen 59: 879–886

    Google Scholar 

  • Butler M.G., Hodes M.E., Conneally P.M., Biegel A.A., Wright J.C. (1984) Linkage analysis in an large kindred with autosomal-dominant transmission of polyglandular autoimmune disease type II. Am J Med Gen 18: 61–65

    Article  CAS  Google Scholar 

  • Chen S., Sawicka J., Betterle C. et al. (1996) Autoantibodies to steroidogenic enzymes in auto immune polyglandular syndrome, addison’s disease and premature ovarian failure. J Clin Endocrinol Metab 81: 1871–1876

    Article  PubMed  CAS  Google Scholar 

  • Claude H. (1908) Insuffisance pluriglandulaire endocrinienne. J Physiol Pathol Gen 10: 469–480

    Google Scholar 

  • Csaszar T., Patakfalvi A. (1992) Treatment of polyglandular autoimmune syndrome with cyclosporin A. Acta Med Hung 49: 187–193

    PubMed  Google Scholar 

  • De Bellis A., Bizzarro A., Rossi R., Paglionico V.A., Criscuolo T., Lombardi G., Bellastella A. (1993) Remission of subclinical adrenocortical failure in subjects with adrenal auto antibodies. J Clin Endocrinol Metab 76: 1002–1007

    Article  PubMed  Google Scholar 

  • Drexhage H.A., Wulffraat N.M. (1994) Endocrine auto immune diseases. Neth J Med 45: 285–293

    PubMed  CAS  Google Scholar 

  • Eisenbarth G.S. (1986) Typ 1 diabetes mellitus: chronic autoimmune disease. N Engl J Med 314: 1360–1368

    Article  PubMed  CAS  Google Scholar 

  • Hashizume K., Ichikawa K., Nishii Y. et al. (1992) Effect of administration of thyroxine on the risk of postpartum recurrence of hyperthyroid Graves’ disease. J Clin Endocrinol Metab 75: 6–10

    Article  PubMed  CAS  Google Scholar 

  • Herrod H.G. (1990) Chronic mucocutaneous candidiasis in childhood and complications of non-candida infection: areport of the pediatric immunodefiency Collaborative Study Group. J Pediatr 116: 377–382

    Article  PubMed  CAS  Google Scholar 

  • Kahaly G., Förster G., Otto E., Hansen C., Schulz G. (1997) Typ 1 Diabetes mellitus als Teil des polyglandulären Autoimmunsyndroms. Diab Stoffw 6: 19–27

    Google Scholar 

  • Leshin M. (1985) Polyglandular auto immune syndromes. Am J Med Sci 290(2): 77–88

    Article  PubMed  CAS  Google Scholar 

  • Mandroup-Poulsen T., Nerup J., Reimers J.I. et al. (1996) Cytokines and the endocrine System. II roles in substrate metabolism, modulation of thyroidal and pancreatic endocrine cell functions and auto immune endocrine diseases. Eur J Endocrinol 134: 21–30

    Article  Google Scholar 

  • Nagamine K., Kudoh J., Minoshima S., Kawasaki K., Asakawa S., Ho F., Shimizu N. (1996) Isolation of cDNA for a novel human protein KNP-I that is homologous to the E. coli SCRP-27 A protein from the auto immune polyglandular diease type I (APECED) region of chromosome 21q22.3. Biochem Biophys Res Comm 225: 606–618

    Article  Google Scholar 

  • Neufeld M., MaclAren N., Blizzard R.M. (1980) Autoimmune polyglandular syndromes. Pediatr Ann 4: 125–136

    Google Scholar 

  • Neufeld M., Maclaren N., Blizzard R.M. (1981) Two types of autoimmune Addison’s disease associated with different polyglandular auto immune (PGA) syndromes. Medicine 60: 355–362

    Article  PubMed  CAS  Google Scholar 

  • Pfützner A., Forst T., Schilling B., Saur G., Beyer J., Kahaly G. (1996) Prävalenz von GAD 65 Auto-antikörpern bei Patienten mit autoimmunogenen Schilddrüsenerkrankungen. Diab Stoffw 5: 132–133

    Google Scholar 

  • Pozzilli P., Carotenuto P., Delitala G. (1994) Lymphocytic traffk and homing into target tissue and the generation of endocrine autotimmunity. Clin Endocrinol 41: 545–554

    Article  CAS  Google Scholar 

  • Riley W.J. (1992) Autoimmune polyglandular syndromes. Horm Res 38 (suppl. 2):9–15

    Article  PubMed  Google Scholar 

  • Rongen-Westerlaken C., Drop S.L.S., Van Den Anker J.N. (1986) Primary adrenocortical insufficiency in chlddhood. Acta Endocrinol 279 (Suppl.):279–283

    CAS  Google Scholar 

  • Rose N.R. (1989) Pathogenic mechanism in auto immune disease. Clin Imunol Immunopathol 53: 7–16

    Article  Google Scholar 

  • Schloot N., Eisenbarth G.S. (1995) Isohormonal therapy of endocrine autoimmunity. Immunol Today 16: 289–294

    Article  PubMed  CAS  Google Scholar 

  • Schmidt M.B. (1926) Eine biglanduläre Erkrankung (Nebenniere und Schilddrüse). Verh Dtsch Ges Path 21: 212

    Google Scholar 

  • Scordis N., Maclaren N. (1988) Immunogenetics of autoimmune polyglandular syndromes. In: N. R. Farid (ed) Immunogenetic of endocrine disorders. Liss, New York, pp 373

    Google Scholar 

  • Uibo R., Harik E., Peterson P., Perheentupa J., Aranko S., Pelkonen R., Krohn K.J.E. (1994) Autoantibodies to cytochrome P450 enzymes, P450 scc, P450 c17 and P450 c21 in autoimmune polyglandular disease types land II and in isolated Addison’s disease. J Clin Endocrinol Metab 78: 323–328

    Article  PubMed  CAS  Google Scholar 

  • Wagner R., Genovese S., Bosi E. et al. (1994) Slow metabolic deterioration towards diabetes in islet cell antibody positive patients with auto immune polyendocrine disease. Diabetologica 37: 365–371

    Article  CAS  Google Scholar 

  • Whitaker J., Landing B.H., Esselborn V.M., Williams R.R. (1956) The syndrome of Juvenile hypoadrenocorticism, hypoparathyroidism and superficial moniliasis. J Clin Endocrinol Metab 16: 1374–1387

    Article  PubMed  Google Scholar 

  • Yangxin L., Song Y-H., Rais N., Connor E., Schatz D., Muir A., MacLaren N. (1996) Autoantibodies to the etracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidismus. J Clin Invest 97: 910–914

    Article  Google Scholar 

Literatur zu Abschn. 9.2

  • Agarwal S.K., Kester M.B., Debelenko L.V. et al. (1997) Germline mutations of the MEN 1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet 6: 1169–1175

    Article  PubMed  CAS  Google Scholar 

  • Bertherat J., Turpin G., Rauch C., Li J.Y., Epelbaum J., Sassolas G., Schaison G. (1994) Presence of somatostatin receptors negatively coupled to adenylate cyclase in ectopic growth hormone-releasing hormone-and a-subunit-secreting tumors from acromegalic patients responsive to octreotide. J Clin Endocrinol Metab 79: 1457–1464

    Article  PubMed  CAS  Google Scholar 

  • Brandi M.L., Aurbach G.D., Fitzpatrick L.A. et al. (1986) Parathyroid mitogenic activity in plasma from patients with familial multiple endocrine neoplasia type 1. N Engl J Med 314: 1287

    Article  PubMed  CAS  Google Scholar 

  • Chandrasekharappa S.C., Guru S.C., Manickam P. et al. (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276: 404–407

    Article  PubMed  CAS  Google Scholar 

  • Demeure M.J., Klonoff D.C., Karam J.H., Duh Q.Y., Clark O.H. (1991) Insulinomas associated with multiple endocrine neoplasia type I: The need for a different surgical approach. Surgery 110: 998–1005

    PubMed  CAS  Google Scholar 

  • Dobnig H., Steppan V., Leb G., Wolf G., Buchfelder M., Krejs G.J. (1996) Recovery from severe osteoporosis following cure from ectopic ACTH syndrome caused by an appendix carcinoid. J Intern Med 239: 365–369

    Article  PubMed  CAS  Google Scholar 

  • Doppman J.L., Chang R., Fraker D.L. et al. (1995) Localization of insulinomas to regions of the pancreas by intra-arterial stimulation with calcium. Ann. Intern Med 123: 269–273

    Article  PubMed  CAS  Google Scholar 

  • Friedman E., Sakaguchi K., Bale A.E. et al. (1989) Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N Engl J Med. 321: 213–218

    Article  PubMed  CAS  Google Scholar 

  • Jensen R.T., Fraker D.L. (1994) Zollinger-Ellison syndrome. JAMA 271: 1429–1435

    Article  PubMed  CAS  Google Scholar 

  • Knudson A.G. (1971) Mutation and cancer. Proc Natl Acad Sci USA 68: 820–823

    Article  PubMed  Google Scholar 

  • Larsson C., Calender A., Grimmond S., Giraud S., Hayward N.K., Teh B., Farnebo F. (1995) Molecular tools for pesymptomatic testing in multiple endocrine neoplasia type 1. J Intern Med 238: 239–244

    Article  PubMed  CAS  Google Scholar 

  • Lehy T., Cadiot G., Ruszniewski P., Bonfils S. (1992) Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with Zollinger-Ellison-syndrome. Gut 33: 1275–1279

    Article  PubMed  CAS  Google Scholar 

  • Lemmens I., Van-de V.W., Kas K. et al. (1997) Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MENI. Hum Mol Genet 6: 1177–1183

    Article  CAS  Google Scholar 

  • MacFarlane M.P., Fraker D.L., Alexander H.R., Norton J.A., Lubensky I., Jensen R.T. (1995) Prospektive study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1. Surgery 118: 973–980

    Article  PubMed  CAS  Google Scholar 

  • Mignon M., Ruszniewski P., Podevin P., Sabbagh L., Cadiot G., Rigaud O., Bonfils S. (1993) Current approach to the management of gastrinoma and insulinoma in adults with multiple endocrine neoplasia type I. World J Surg 17: 489–497

    Article  PubMed  CAS  Google Scholar 

  • Schröder S., Padberg B., Capella C., Frilling A., Klöppel G., Heitz P.U. (1994) Multiple endokrine Neoplasie Typ 1 (MEN 1). Pathologe. 15: 150–157

    Article  PubMed  Google Scholar 

  • Skogseid B., Oberg K., Benson L. et al. (1987) A standardized meal stimulation test of the endocrine pancreas for early detection of pancreatic endocrine tumors in multiple endocrine neoplasia type 1 syndrome: five years experience. J Clin Endocrinol Metab 64: 1233–1240

    Article  PubMed  CAS  Google Scholar 

  • Skogseid S., Rastad J., Gobl A. et al. (1995) Adrenal lesion in multiple endocrine neoplasia type 1. Surgery 118: 1077–1082

    Article  PubMed  CAS  Google Scholar 

  • Takayamy T., Kameya T., Inagaki K. et al. (1993) MEN type I associated with mediastinal carcinoid producing parathyroid hormone, calcitonin and chorionic gonadotropin. Pathol Res Pract 189: 1090–1096

    Article  Google Scholar 

  • Thakker R.V. (1994) The role of molecular genetics in screening for multiple endocrine neoplasia type 1. Endocrinol Metab Clin North Am 23: 117–135

    PubMed  CAS  Google Scholar 

  • Thompson N.W. (1992) Surgical treatment of the endocrine pancreas and Zollinger-Ellison syndrome in the MEN 1 syndrome. Henry Ford Hosp Med J 40: 195–198

    PubMed  CAS  Google Scholar 

  • Thompson N.W. (1995) The surgical management of hyperparathyroidism and endocrine disease of the pancreas in themultiple endocrine neoplasia type 1 patient. J Intern Med 238: 269–280

    Article  PubMed  CAS  Google Scholar 

  • Trump D., Farren B., Wooding C. et al. (1996) Clinical studies of multiple endocrine neoplasia type 1 (MEN1). Q J Med 89: 653–669

    Article  CAS  Google Scholar 

  • Underdahl L.O., Woolner L.B., Black B.M. (1953) Multiple endocrine adenomas. Report of eight cases in which parathyroids, pituitary and pancreatic islets were involved. J Clin Endocr 13: 20–27

    Article  PubMed  CAS  Google Scholar 

  • Weinel R.J., Kisker O., Joseph K., Welcke U., Zaraca F., Rothmund M. (1994) Die Somatostatinrezeptor-Szintigraphie in der präoperativen Lokalisationsdiagnostik endokriner gastrointestinaler Tumoren. Chirurg 65: 849–855

    PubMed  CAS  Google Scholar 

  • Weinel R.J., Neuhaus C., Klotter H.J., Trautmann M.E., Arnold R., Rothmund M. (1993) Standardisiertes chirurgisches Konzept zur Diagnostik und Therapie des Zollinger-EllisonSyndroms. Dtsch Med Wochenschr 118: 485–492

    Article  PubMed  CAS  Google Scholar 

  • Wermer P. (1954) Genetic aspects of adenomatosis of endocrine glands. Amer J Med 16: 363–371

    Article  PubMed  CAS  Google Scholar 

Literatur zu Abschn. 9.3

  • Abdelmoumene N., Schlumberger M., Gardet P., Roche A., Travagli J.P., Francese C., Parmentier C. (1994) Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma. Br J Cancer 69: 1141–1144

    Article  PubMed  CAS  Google Scholar 

  • Behr T.M., Wulst E., Radetzky S. et al. (1997) Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy. Doxorubicin potentlates the therapeutic efficacy of radiolabelled antibodies in a radioresistrant tumor type. Cancer Res 57: 5309–5319

    PubMed  CAS  Google Scholar 

  • Berndt I., Reuter M., Saller B. et al. (1998) A new hot spot for mutatIOns m the ret Protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A. J Clin Endocrinol Metab 83: 770–774

    Article  PubMed  CAS  Google Scholar 

  • Bonnin F., Schlumberger M., Gardet P. et al. (1994) Screening for adrenal medullary disease in patients with medullary thyroid carcinoma. J Endocrinol Invest 17: 253–257

    PubMed  CAS  Google Scholar 

  • Bravo E.L. (1994) Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocr Rev 15(3):356–368

    PubMed  CAS  Google Scholar 

  • Buhr H.J., Kallinowski F., Raue F., Frank-Raue K., Herfarth C. (1993) Microsurgical neck dissection for occultly metastasizing medullary thyroid carcinoma. Three-year results. Cancer 72: 3685–3693

    Article  PubMed  CAS  Google Scholar 

  • Donis Keller H., Dou S., Chi D. et al. (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2: 851–856

    Article  PubMed  CAS  Google Scholar 

  • Eng C., Clayton D., Schuffenecker I. et al. (1996) The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 276: 1575–1579

    Article  PubMed  CAS  Google Scholar 

  • Evans D.B., Lee J.E., Merrell R.C., Hickey R.C. (1994) Adrenal medullary disease in multiple endocrine neoplasia type 2: appropriate mangement. Endocrin Metab Clin N Am 23: 167–176

    CAS  Google Scholar 

  • Frank-Raue K., Hoppner W., Frilling A. et al. (1996) Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. German Medullary Thyroid Carcinoma Study Group. J Clin Endocrinol Metab 81: 1780–1783

    Article  PubMed  CAS  Google Scholar 

  • Frank-Raue K., Kratt T., Höppner W., Buhr H., Ziegler R., Raue F. (1996) Diagnosis and management of phhenochromocytomas in patients with multiple endocrine neoplasia type 2-relevance of specific mutations in the RET proto-oncogene. Eur J Endocrinol 135: 222–225

    Article  PubMed  CAS  Google Scholar 

  • Frank-Raue K., Raue F., Buhr H.J., Baldauf G., Lorenz D., Ziegler R. (1992) Localization of occult persisting medullary thyroid carcimoma before microsurgical reoperation: high sensitivlty of selectIve venous catheterization. Thyroid 2:113–117

    Article  PubMed  CAS  Google Scholar 

  • Frank-Raue K., Ziegler R., Raue F. (1993) The use of octreotide in the treatment of medullary thyroid carcinoma. Horm Metab Res 27: 44–47

    CAS  Google Scholar 

  • Gagel R.F., Levy M.L., Donovan D.T., Alford B.R., Wheeler T., Tschen J.A. (1989) Multiple endocrine neoplasia type 2a associated with cutaneous lichen amyloidosis. Ann Intern Med 111: 802–806

    Article  PubMed  CAS  Google Scholar 

  • Gagel R.F., Tashjian A.H. Jr., Cummings T. et al. (1988) The clinical outcome of prospective screening for multiple endocrine neoplasla type 2a. An 18-year experience. N Engl J Med 318: 478–484

    Article  PubMed  CAS  Google Scholar 

  • Gimm O, Dralle H. (1997) Reoperation in metastasizing medullary thyroid carcmoma: Is a tumor stage-oriented approach justified. Surgery 122: 1124–1131

    Article  PubMed  CAS  Google Scholar 

  • Grauer A., Raue F. (1997) Diagnostic value of the peptides of calcitonin gene. In: Schmldt-Gayk H., Blind E., Roth H.J. (eds) Calcium regulating hormones and markers of bone metabolism; measurement and interpretation. Clin Lab Publik, Heidelberg, pp 85–93

    Google Scholar 

  • Grauer A., Raue F., Gagel R.F. (1990) Changing concepts in the management of hereditary and sporadic medullary thyroid carcmoma. Endocrinol Metab Clin North Am 19: 613–635

    PubMed  CAS  Google Scholar 

  • Hofstra R.M., Landsvater R.M., Ceccherini I. et al. (1994) A mutation in the RET proto-oncogene associated with multiple endocnne neoplasla type 2B and sporadic medullary thyroid carcinoma. Nature 367: 375–376.

    Article  PubMed  CAS  Google Scholar 

  • Hofstra R.M., Sijmons R.H., Stelwagen T. et al. (1996) RET mutation screening in familial cutaneous lichen amyloidosis and in skin amyloidosis associated with multiple endocrine neoplasia. J Invest Dermatol 107: 215–218

    Article  PubMed  CAS  Google Scholar 

  • Ito S., Iwashita T., Asai N., Mukarami H., et al. (1997) Biological properties of RET with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyrold carcmoma, and Hirschsprung’s disease phenotype. Cancer Res 57: 2870–2872

    PubMed  CAS  Google Scholar 

  • Juweid M., Sharkey R.M., Swayne L.C., Goldenberg D.M. (1997) Improved selection of patients for reoperation for medullary thyroid cancer by imaging with radiolabeled antiearcinoembryonic antigen antibodies. Surgery 122: 1156–1165

    Article  PubMed  CAS  Google Scholar 

  • Komminoth P. (1997) The RET proto-oncogene in medullary and papillary thyroid carcinoma. Molecular features, pathophysiology and clincal implications. Virchows Arch 431: 1–9

    Article  PubMed  CAS  Google Scholar 

  • Lee J.E., Curley S.A., Gagel R.F., Evans D.B., Hickey R.C. (1996) Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma. Surgery 120: 1064–70

    Article  PubMed  CAS  Google Scholar 

  • Lupoli G., Cascone E., Arlotta F., Vitale G., Celentano L., Salvatore M., Lombardi G. (1996) Treatment of advanced medullary thyroid carcinoma with a combination of recombinant interferon u-2b and octreotide. Cancer 78: 1114–1148

    Article  PubMed  CAS  Google Scholar 

  • Modigliani E., Vasen H.M., Raue K. et al. (1995) Pheochromocytoma in multiple endocnne neoplasia type 2: European study. J Intern Med 238: 363–367

    Article  PubMed  CAS  Google Scholar 

  • Moers A.M., Landsvater R.M., Schaap C. et al. (1996) Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large family. Am J Med 101: 635–641

    Article  PubMed  CAS  Google Scholar 

  • Mulligan L.M., Eng C., Healey C.S. et al. (1994) Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nature Genet 6: 70–74

    Article  PubMed  CAS  Google Scholar 

  • Mulligan L.M., Kwok J.B., Healey C.S. et al. (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363: 458–460

    Article  PubMed  CAS  Google Scholar 

  • Ponder B.A., Ponder M.A., Coffey R., Pembrey M.E., Gagel R.F., Telenius-Berg M., Semple P., Easton D.F. (1988) Risk estimation and screening in families of patients with medullary thyroid carcinoma. Lancet 1: 397–401

    Article  PubMed  CAS  Google Scholar 

  • Raue F., Frank Raue K., Grauer A. (1994) Multiple endocrine neoplasia type 2. Clinical features and screening. Endocrinol Metab Clin North Am 23: 137–156

    PubMed  CAS  Google Scholar 

  • Raue F., Geiger S., Buhr H., Frank-Raue K., Ziegler R. (1993) Prognostische Bedeutung des Kalzitonin-Screenings beim familiären medullären Schilddrüsenkarzinom. Dtsch Med Wochenschr 118: 49–52

    Article  PubMed  CAS  Google Scholar 

  • Raue F., Kraimps J.L., Dralle H. et al. (1995) Primary hyperparathyroidism in multiple endocrme neoplasia type 2A. J Intern Med 238: 369–373

    Article  PubMed  CAS  Google Scholar 

  • Saad M.F., Ordonez N.G., Rashid R.K., Guido J.J., Hili C.S., Jr., Hikkey R.C., Samaan N.A. (1984) Medullary carcinoma of the thyroid: a study of the clinical features and prognostic factors in 161 patients. Medicine 63: 319–342

    Article  PubMed  CAS  Google Scholar 

  • Santoro M., Carlomagno F., Romano A. et al. (1995) Activation of RET as a dominant transforming gene by germline mutations of MEN 2A and MEN 2B. Science 267: 381–383

    Article  PubMed  CAS  Google Scholar 

  • Scherübl H., Raue F., Ziegler R. (1990) Combination chemotherapy of advanced medullary and differentiated thyroid cancer. J Cancer Res Clin Oncol 116: 21–23

    Article  PubMed  Google Scholar 

  • Smith D.P., Houghton C., Ponder B.A. (1997) Germline mutation of RET codon 882 in two cases of de novo MEN 2b. Oncogene 15: 1213–1217

    Article  PubMed  CAS  Google Scholar 

  • Trupp M., Arena E., Fainzilber M. et al. (1996) Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 381: 785–789

    Article  PubMed  CAS  Google Scholar 

  • van Heyningen V. (1994) Genetics. One gene-four syndromes. Nature 367: 319–320

    Article  PubMed  Google Scholar 

  • Vasen H.F., van der Feltz M., Raue F. et al. (1992) The natural course of multiple endocrine neoplasia type IIb. A study of 18 cases. Arch Intern Med 152: 1250–1252

    Article  PubMed  CAS  Google Scholar 

  • Wu L.T., Averbuch S.D., Ball D.W., de Bustros A., Baylin S.B., McGuire W.P. 3rd. (1994) Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine. Cancer 73: 432–436

    Article  PubMed  CAS  Google Scholar 

  • Zink A., Blind E., Raue F. (1992) Determination of serum calcitonin by immunometric two-site assays in normal subjects and patients with medullary thyroid carcinoma. Eur J Clin Chem Clin Biochem 30: 831–835

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. A. Grauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Höppner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Lorenz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. Schilling
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Klinik IV, Universitätsklinikum Tübingen, Otfried-Müller-Straße 10, 72076, Tübingen, Deutschland

    Peter P. Nawroth

  2. Abteilung Innere Medizin I, Medizinische Universitätsklinik und Poliklinik Heidelberg, Bergheimer Straße 58, 69115, Heidelberg, Deutschland

    Reinhard Ziegler

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Grauer, A., Höppner, W., Lorenz, A., Schilling, T. (2001). Komplexe endokrine Störungen. In: Nawroth, P.P., Ziegler, R. (eds) Klinische Endokrinologie und Stoffwechsel. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56784-1_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56784-1_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62970-9

  • Online ISBN: 978-3-642-56784-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation